Status:
NOT_YET_RECRUITING
Assessment the Cancer Risk of Indeterminate Thyroid Nodules Through Integration of Clinical, Ultrasonographic and Multiomic Features
Lead Sponsor:
University of Cagliari
Collaborating Sponsors:
Prof. Pietro Giorgio Calò
Dott. Gian Luigi Canu
Conditions:
Thyroid Nodule
Thyroid Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Indeterminate thyroid nodules have a mild risk of malignancy (15-30%). The aim of our study is to individuate new biomarkers of thyroid carcinoma through multiomic analyses of blood samples and of spe...
Eligibility Criteria
Inclusion
- Patients with indeterminate thyroid nodules (Class III and Class IV according to Bethesda Classification of thyroid nodules)
Exclusion
- Patients with concomitant thyroid nodules of Bethesda Class V or Class VI
- Patients with preoperative diagnosis of lymph node metastases of central or lateral neck compartment
- Patients with distant metastases
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
256 Patients enrolled
Trial Details
Trial ID
NCT05428371
Start Date
January 1 2023
End Date
December 31 2027
Last Update
June 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AOU Cagliari
Cagliari, CA, Italy, 09100